Trial of FK614 in Type 2 Diabetics Inadequately Controlled on a Sulfonylurea
NCT ID: NCT00036192
Last Updated: 2011-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
200 participants
INTERVENTIONAL
2002-02-28
2006-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
FK614
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Has been taking current sulfonylurea (SU) for at least 3 months. Subjects currently taking metformin may be eligible to be switched.
* Has not received any oral antidiabetic medication other than an SU or taken regularly prescribed insulin for at least 3 months
Exclusion Criteria
* Has uncontrolled hypertension, i.e., systolic BP \>170 or diastolic BP \> 95 mm Hg.
* History of congestive heart failure
25 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Astellas Pharma US, Inc.
INDUSTRY
Astellas Pharma Inc
INDUSTRY
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
International Institute of Clinical Research, Inc.
Ozark, Alabama, United States
Arizona Research Associates
Tucson, Arizona, United States
OCCR @ East Gate Medical Center
Cypress, California, United States
Clinical Trials of St. Jude Heritage Md Grp
Fullerton, California, United States
Research Foundation of America
Los Angeles, California, United States
Progressive Clinical Research
Vista, California, United States
Diablo Clinical Research, Inc.
Walnut Creek, California, United States
Center for Diabetes and Endocrine Care
Hollywood, Florida, United States
Physician's Office
Miami, Florida, United States
University of Miami, Diabetes Center
Miami, Florida, United States
Baptist Diabetes Associates
Miami, Florida, United States
Central Florida Clinical Studies
Ocoee, Florida, United States
Clireco, Inc.
Tamarac, Florida, United States
The Emory Clinic
Atlanta, Georgia, United States
East-West Medical Institute
Honolulu, Hawaii, United States
McConnehey Family Medicine
Nampa, Idaho, United States
Physician's Office
Peoria, Illinois, United States
Clinical Research, Inc.
Waltham, Massachusetts, United States
Radiant Research - Minneapolis
Edina, Minnesota, United States
Physician's East
Greenville, North Carolina, United States
Cleveland Clinic
Cleveland, Ohio, United States
Radiant Research
Mogadorf, Ohio, United States
Physician's Office
Portland, Oregon, United States
Physicians for Clinical Research
Camp Hill, Pennsylvania, United States
Fleetwood Medical Associates
Fleetwood, Pennsylvania, United States
Founders Research Corp.
Philadelphia, Pennsylvania, United States
SFM Clinical Trials
Scotland, Pennsylvania, United States
Heartland Medical PC
New Tazewell, Tennessee, United States
University of Texas Southwestern Medical Center
Dallas, Texas, United States
Baylor College of Medicine
Houston, Texas, United States
Mercury Research, Inc.
Houston, Texas, United States
Diabetes / Glandular Disease Research Associates
San Antonio, Texas, United States
Sam Clinical Research Center
San Antonio, Texas, United States
McGuire Research Institute
Richmond, Virginia, United States
Physician's Office
Spokane, Washington, United States
University Physicians Internal Medicine
Huntington, West Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FA-614-0004
Identifier Type: -
Identifier Source: org_study_id